Literature DB >> 25720556

Engineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecan.

T Ramasamy1, H B Ruttala, J Y Choi, T H Tran, J H Kim, S K Ku, H G Choi, C S Yong, J O Kim.   

Abstract

We developed a highly stable lipid-polymer nanoarchitectural platform for effective combination therapy of doxorubicin and irinotecan in the polyelectrolyte complex nanoparticle core, followed by incorporation of the whole assembly into a lecithin bilayer. It shows great potential for the treatment of a broad range of cancers.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25720556     DOI： 10.1039/c5cc00482a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  16 in total

1.  Combination of Oxaliplatin and Vit.E-TPGS in Lipid Nanosystem for Enhanced Therapeutic Efficacy in Colon Cancers.

Authors:  Yanlei Wang; Xiang Zhang; Wenqiang Zhang; Hao Dong; Wenjie Zhang; Jiajia Mao; Yong Dai
Journal:  Pharm Res       Date:  2018-01-08       Impact factor: 4.200

2.  Bioflavonoid Fisetin Loaded α-Tocopherol-Poly(lactic acid)-Based Polymeric Micelles for Enhanced Anticancer Efficacy in Breast Cancers.

Authors:  Lei Wang; De-Zhong Zhang; Yu-Xia Wang
Journal:  Pharm Res       Date:  2016-12-21       Impact factor: 4.200

3.  Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration.

Authors:  Fakhar Ud Din; Ju Yeon Choi; Dong Wuk Kim; Omer Mustapha; Dong Shik Kim; Raj Kumar Thapa; Sae Kwang Ku; Yu Seok Youn; Kyung Taek Oh; Chul Soon Yong; Jong Oh Kim; Han-Gon Choi
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma.

Authors:  Bing Wang; Xiu-Chun Yu; Song-Feng Xu; Ming Xu
Journal:  J Nanobiotechnology       Date:  2015-03-21       Impact factor: 10.435

5.  Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers.

Authors:  Long-Bin Cao; Sha Zeng; Wei Zhao
Journal:  Nanoscale Res Lett       Date:  2016-06-21       Impact factor: 4.703

6.  Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.

Authors:  DanDan Zhang; Yan Yan Kong; Jia Hui Sun; Shao Jie Huo; Min Zhou; Yi Ling Gui; Xu Mu; Huan Chen; Shu Qin Yu; Qian Xu
Journal:  Int J Nanomedicine       Date:  2017-03-16

7.  Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy.

Authors:  Hima Bindu Ruttala; Thiruganesh Ramasamy; Bijay Kumar Poudal; Yongjoo Choi; Ju Yeon Choi; Jeonghwan Kim; Sae Kwang Ku; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Oncotarget       Date:  2017-02-28

8.  Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis.

Authors:  Li Zhang; Junli Chang; Yongjian Zhao; Hao Xu; Tengteng Wang; Qiang Li; Lianping Xing; Jing Huang; Yongjun Wang; Qianqian Liang
Journal:  Int J Nanomedicine       Date:  2018-04-04

9.  Docetaxel-loaded multilayer nanoparticles with nanodroplets for cancer therapy.

Authors:  Keun Sang Oh; Kyungim Kim; Byeong Deok Yoon; Hye Jin Lee; Dal Yong Park; Eun-Yeong Kim; Kiho Lee; Jae Hong Seo; Soon Hong Yuk
Journal:  Int J Nanomedicine       Date:  2016-03-16

10.  Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model.

Authors:  Neha N Parayath; Hayley Nehoff; Samuel E Norton; Andrew J Highton; Sebastien Taurin; Roslyn A Kemp; Khaled Greish
Journal:  Int J Nanomedicine       Date:  2016-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.